• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
G2 Intelligence Has Some Exciting News to Share!

G2 Intelligence Has Some Exciting News to Share!

by G2 Intelligence Staff | Sep 22, 2023 | News, Open Content

G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight

Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine

Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine

by G2 Intelligence Staff | Sep 14, 2023 | OLP, Webinars

Our upcoming event will provide lab leaders with analysis of recent legal and regulatory developments, enforcement trends, and more

The Diagnostics Pipeline: FDA Proceeds without Congress Over LDTs Reform

The Diagnostics Pipeline: FDA Proceeds without Congress Over LDTs Reform

by Glenn S. Demby | Aug 29, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Diagnostics Pipeline: FDA Launches Pilot for Cancer Companion Diagnostic LDTs

The Diagnostics Pipeline: FDA Launches Pilot for Cancer Companion Diagnostic LDTs

by Glenn S. Demby | Jul 31, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

New program aims to provide greater transparency on the recommended performance characteristics of such tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Congress Moves to Require Medicare Coverage of Multi-Cancer Early Detection Tests

Congress Moves to Require Medicare Coverage of Multi-Cancer Early Detection Tests

by Glenn S. Demby | Jul 31, 2023 | Essential, Legislation-nir, National Lab Reporter

Federal lawmakers have renewed efforts to pass legislation ensuring Medicare coverage of multi-cancer early detection (MCED) tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com